N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands
N‐(4‐(4‐(2‐Halogenophenyl)piperazin‐1‐yl)butyl) Substituted Cinnamoyl Amide Derivatives as Dopamine D2 and D3 Receptor Ligands
复制标题
N-(4-(4-(2-卤代苯基)哌嗪-1-基)丁基)取代肉桂酰酰胺衍生物作为多巴胺 D2 和 D3 受体配体
DOI:
10.1002/ardp.200600196
复制
发表时间:
2007
影响因子:
5.1
通讯作者:
H. Stark
中科院分区:
文献类型:
--
作者:
O. Saur;Anneke E. Hackling;S. Perachon;J. Schwartz;P. Sokoloff;H. Stark
A series of eight substituted N‐(4‐(4‐(2‐halogenophenyl)piperazin‐1‐yl)butyl)‐3‐phenylacryl amide derivatives have been synthesized and screened for binding affinities at dopamine hD2 and hD3 receptors. All compounds have shown high to remarkable receptor affinities and some have led to distinct selectivity for D3 receptors. Highest D3‐receptor affinity has been observed for 3‐(4‐aminophenyl)‐N‐(4‐(4‐(2‐fluorophenyl)piperazin‐1‐yl)butyl)acryl amide (hD3 Ki 0.9 nM; hD2 Ki 17.4 nM). Selectivity ratio has been best for 3‐(4‐chlorophenyl)‐N‐(4‐(4‐(2‐fluorophenyl)piperazin‐1‐yl)butyl)acryl amide with a 56‐fold preference for hD3 versus hD2. A functional activity test has been performed by a mitogenesis test for N‐(4‐(4‐(2‐fluorophenyl)piperazin‐1‐yl)butyl)‐3,3‐diphenylacryl amide, which, surprisingly, has shown full agonist properties.